Fundamentals

Valuation

Metric	Q4	Q2	Δ in %
EV/EBITDA	28.29	80.96	63.11
Graham Fair Price	-0.71	47.59	47.93
PEG	100.00	4.00	0.00
Price/Book	13.57	5.30	4.67
Price/Cash Flow	72.15	136.51	79.29
Prices/Earnings	31.74	31.24	23.72
Price/Sales	34.74	22.71	16.85
Price/FCF	72.15	136.51	79.29
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q2	Δ in %
Gross Profit Margin	5.31	0.56	0.53
Operating Margin	0.74	0.26	0.26
ROA	-6.05	0.02	0.02
ROE	0.05	0.04	-13.79
ROIC	0.03	0.03	-9.49
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q2	Δ in %
Debt QOQ	-0.06	1.07	-94.50
Dividends QOQ	0.05	< 0.005	-98.79
EBIT QOQ	0.08	0.06	-29.88
EPS QOQ	0.00	0.08	100.00
FCF QOQ	-0.16	-0.34	-119.15
Revenue QOQ	0.11	0.03	-74.69
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	122.10	140.19	14.82
Days Sales Outstanding (DSO)	73.93	73.35	-0.78
Inventory Turnover	0.74	0.64	-12.91
Debt/Capitalization	0.40	0.36	-10.64
Quick Ratio	1.21	1.22	0.78
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q2	Δ in %
Book Value	45.56	48.73	6.94
Cash	2.03	2.19	8.06
Capex	-0.18	-0.25	-38.57
Free Cash Flow	2.68	1.89	-29.45
Revenue	12.62	11.37	-9.87
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q2	Δ in %
Current Ratio	2.11	2.21	4.73
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.45	7.58	1.86
Naive Interpretation	Member

06 - Financial Health · Bad

Rating